Post on 16-May-2015
description
Novartis & Alcon
Jérémie LORRAIN & Kelly BLASCO
The takeover
INTRODUCTION
What is a Takeover?
Friendly Hostile
OVERVIEW
I. Presentation of the companies
II. Reasons of the takeover
III. Stock Market
IV. How does Novartis finance it?
Novartis
• Swiss pharmaceutical company
• Created in 1996
• 2009 turnover: $ 44,3 billion
• Employees: 100 000
Alcon
• American pharmaceutical firm
• Founded in 1945 by R.Alexander & W.Coner
• 2008 turnover: $ 6 293 billion
• Employees: 15 000
Reasons of the takeover
• 28 billion dollars
• Strengthen innovation power & diversify its range of medication
• Together they cover more than 70% of the global vision care sector
• Benefice for the shareholders, employees and patients
Stock Market - Alcon
19th February stock price : $ 159.08
15th March stock price: $162.48
Stock Market - Novartis
• 5th february: Novartis’ shares were worth 57,75 dollars
• Today: 58,35 dollars
How does Novartis finance it?
• $14 billion to be financed
• Strong cash flow
• Mix of bonds and loans
• Selling shares
Conclusion
Future success ?